Antimicrobial performance of mesoporous titania thin films: role of pore size, hydrophobicity, and antibiotic release by Atefyekta, Saba et al.
© 2016 Atefyekta et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php 
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you 
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission 
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
International Journal of Nanomedicine 2016:11 977–990
International Journal of Nanomedicine Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
977
O r I g I N a l  r e s e a r c h
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/IJN.S95375
antimicrobial performance of mesoporous titania 









1Department of Chemistry and 
Chemical Engineering, Chalmers 
University of Technology, Gothenburg, 
sweden; 2Department of chemical 
Engineering, Northeastern University, 
Boston, MA, USA; 3Department 
of Metallurgical and Materials 
Engineering, Middle East Technical 
University, Ankara, Turkey; 4center 
of excellence for advanced Materials 
Research, King Abdulaziz University, 
Jeddah, Saudi Arabia
Abstract: Implant-associated infections are undesirable complications that might arise after 
implant surgery. If the infection is not prevented, it can lead to tremendous cost, trauma, and 
even life threatening conditions for the patient. Development of an implant coating loaded with 
antimicrobial substances would be an effective way to improve the success rate of implants. 
In this study, the in vitro efficacy of mesoporous titania thin films used as a novel antimicrobial 
release coating was evaluated. Mesoporous titania thin films with pore diameters of 4, 6, and 
7 nm were synthesized using the evaporation-induced self-assembly method. The films were 
characterized and loaded with antimicrobial agents, including vancomycin, gentamicin, and 
daptomycin. Staphylococcus aureus and Pseudomonas aeruginosa were used to evaluate their 
effectiveness toward inhibiting bacterial colonization. Drug loading and delivery were studied 
using a quartz crystal microbalance with dissipation monitoring, which showed successful 
loading and release of the antibiotics from the surfaces. Results from counting bacterial colony-
forming units showed reduced bacterial adhesion on the drug-loaded films. Interestingly, the 
presence of the pores alone had a desired effect on bacterial colonization, which can be attributed 
to the documented nanotopographical effect. In summary, this study provides significant promise 
for the use of mesoporous titania thin films for reducing implant infections.
Keywords: mesoporous titania, antibacterial, drug delivery, implant coating
Introduction
When implants are used to restore body functions, they provide a susceptible situation 
for microbial colonization. This is due to the fact that the body’s defense systems are 
much weaker in the presence of a foreign material and that the surface of the implant 
generally is unable to suppress bacterial growth.1–3 These microbial colonization-
derived infections, often referred to as biomaterial associated infections (BAI), are 
some of the most common causes of implant failure.4–7 For example, it has been 
observed that BAI occurs in 1.5%–2.5% of primary hip and knee replacements, which 
in 3.2%–5.6% of cases result in surgical revisions.8
The key pathogenic factor responsible for infection is the development of bacterial 
colonies embedded in a matrix, consisting of proteins, polysaccharides, and DNA, 
called a biofilm on the implant surface.9–11 Such adhesive biofilms are very resistant 
toward the body’s defense mechanisms and antibiotic treatments.1,12 The eradication of 
infections after the formation of a biofilm often necessitates removal and replacement 
of the implant, which results in high costs and trauma for the patient.13–15 Moreover, 
biofilms increase resistance to antibiotic treatments and raise the need for increased 
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dosages to combat infection, something that has been 
reported to cause a series of toxic side effects and cell injuries 
during treatment.16
One of the most practical strategies to fight infection 
would be to apply an implant coating onto medical devices 
that has the capability to release antimicrobial substances.17–19 
This would result in local antibiotic administration at the 
surgical site, which is supposed to be an efficient treatment 
with low risk for systemic side effects. In addition, reduc-
tion of bacterial adhesion to biomedical devices without 
the use of drugs only by manipulating surface properties is 
also an attractive method for hindering infections.1,20 For 
example, decreased adhesion of Staphylococcus aureus and 
Pseudomonas aeruginosa on Ti films has been reported when 
the nanoroughness was increased.21
An effective approach to prevent BAIs would be to com-
bine an antimicrobial release coating with a low bacterial 
adhesive material, for example, by introducing a specific 
nanoroughness.22 One promising coating in this respect is 
mesoporous thin films, since they have roughness values in 
the nano regime combined with the ability to host and deliver 
antimicrobial drugs. The use of mesoporous coatings on 
medical devices has also been highlighted in previous studies 
for improving osseointegration using local administration of 
osteoporosis-reversing drugs.23 Tunable textural properties, 
high surface area, and pore volume are typical properties of 
mesoporous materials, which make them suitable candidates 
for drug-delivery purposes.24–30 For example, a sustained 
release of cephalothin from mesoporous titania-coated 
implants in vitro has recently been reported.31 Moreover, 
Se Park et al have demonstrated that the sustained release of 
high dosages of cephalothin and amoxicillin from mesopo-
rous titania surfaces reversed the functions of five different 
bacterial species.32
The aim of the present study was to evaluate how mesopo-
rous titania thin films coated onto titanium substrates affect the 
formation of bacterial biofilms. The mesoporous films were 
loaded with antibiotics and the role of film thickness and pore 
size were evaluated in vitro. More specifically, mesoporous 
titania thin films, with thicknesses ranging from 250 to 
700 nm and pore diameters of 4, 6, and 7 nm were formed by 
the evaporation-induced self-assembly method. The surfaces 
were loaded with the antimicrobial agents: vancomycin, 
gentamicin, and daptomycin (molecular structures of the 
drugs are shown in Figure 1). The mesoporous film effective-
ness against S. aureus and P. aeruginosa biofilm formation, 
which are two of the most frequent pathogenic species among 
the detected microbial species responsible for BAI, was 
evaluated. Chemistry, crystallinity, morphology, existence 
of long range order, surface energy, and topography of the 
mesoporous titania surfaces were examined using various 
characterization methods. The drug uptake and delivery 
from the mesoporous surfaces were studied using quartz 
crystal microbalance with dissipation monitoring (QCM-D) 
and were correlated to the bacterial attachment analysis. The 
effect of wettability or hydrophilic vs hydrophobic surfaces 
on bacterial function was also investigated here.
Materials and methods
Materials
All chemicals used in this study were purchased from Sigma-
Aldrich Co. (St Louis, MO, USA). Milli-Q water (18.2 M Ω) 
was used for all the preparations.
Preparation of mesoporous titania 
substrates
Cubic mesoporous titania with pore sizes of 4, 6, and 7 nm were 

























































































Figure 1 Molecular structures of the antibiotics used.
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) were used as structure-directing 
agents. P123 has previously been used for the preparation of 
mesoporous titania films.33,34 Larger pores were provided by 
the aid of an organic additive, polypropylene glycol (PPG, 
M
n 
~4,000), which was used as a swelling agent.
A titania precursor solution was prepared by adding 
2.1 g titanium (IV) ethoxide (20%) to 1.6 g concentrated 
hydrochloric acid (37%) under vigorous stirring, forming 
a homogenous solution. The amphiphile (0.5 g) was sepa-
rately dissolved in 8.5 g ethanol under vigorous stirring 
followed by mixing with the precursor solution. The final 
solution was left to stir overnight to achieve a homogenous 
mixture. To obtain uniform thin films of mesoporous titania, 
100 μL of the final solution was spin-coated (7,000 rpm) 
for 1 minute on glass slides (2×2 cm), titanium discs (8 mm 
diameter and 3 mm thickness) and Ti-coated QCM-D sen-
sors using a Spin150 spin coater. The coated substrates 
underwent aging for 1 day at room temperature to obtain 
complete self-assembly. When the swelling agent was used, 
a moderately humid environment (RH=54%) was provided 
by a saturated KNO
3
 aqueous solution in a refrigerator 
(T=4°C±1°C) during the aging process.35,36 Finally, the 
films were calcinated by heating with a heating ramp of 
1°C/min to 350°C, at which temperature they were left 
for 4 hours to remove the template and to cross-link the 
titania. Nonporous titania thin films were formed as control 
samples using the same procedure, but without the addition 
of amphiphiles.
Surface modification
To lower the surface energy of the mesoporous titania thin films, 
they were treated in a 5 wt% dichlorodimethylsilane (DCDMS) 
solution for 1 hour. To ensure a sufficient amount of hydroxyl 
groups on the titania surface, samples were pre-treated in 
water baths at 25°C for 45 minutes. The glass slides were then 
placed in a DCDMS solution for 15 minutes and thereafter 
flushed with chloroform to wash off the unreacted silanol 
groups from the surface, followed by another 45-minute 
treatment in DCDMS.37,38 The modified films were dried 
using nitrogen gas.
Immobilization of antibiotics
Mesoporous titania films were loaded with antibiotics by 
immersing the substrates in antibiotic solutions for 1 hour. 
Vancomycin and gentamicin were dissolved in water 
(1 wt%) and daptomycin was dissolved in methanol (1 wt%). 
DCDMS-treated mesoporous thin films were used to load 
daptomycin, and the non-treated surfaces were used for 
gentamicin and vancomycin.
Material characterization
Transmission electron microscopy (TEM)
TEM was used to visualize the pores in the mesoporous 
titania films. A JEOL-1200EX II microscope (JEOL, Tokyo, 
Japan) operating at 120 kV was used. To image the mate-
rial, mesoporous titania films were scraped off from coated 
glass slides and dispersed in ethanol. One microliter of the 
dispersion was placed onto TEM grids (Carbon 300 mesh, 
Capilor AB, Helsingborg, Sweden) and left to dry before the 
TEM investigation.
Scanning electron microscopy (SEM)
A Leo Ultra 55 electron microscope (Carl Zeiss Meditec AG, 
Oberkochen, Germany) operating at 5 kV was used to analyze 
the morphological properties of the mesoporous titania thin 
films. The pore size, pore direction, and film thickness were 
measured on coated titanium discs and glass microscopy 
slides. No additional sputtering was needed.
Small angle X-ray scattering (SAXS)
The structural phase and the existence of long-range order in 
the mesoporous materials were explored by SAXS measure-
ments. Well-ground powders of mesoporous titania were 
inserted into SAXS sample holders. The measurements were 
performed at MAX-lab in Lund, Sweden; beam station 1911. 
Data were collected with a q-range:
 q=4π θ λsin /  (1)
of 0.1–3.0 nm-1. The wavelength was 0.91 Å, with a beam 
size of 1.2×1.2 Å.
X-ray diffraction (XRD)
Crystallinity of the TiO
2
 films was evaluated by XRD. The 
X-ray diffractometer used was a Bruker D8 advance (Bruker 
Corporation, Billerica, MA, USA) with a radiation wavelength 
of 1.5405 Å (Cu Kα1 radiation). Powders were collected from 
glass substrates and were ground prior to analysis. Analysis was 
performed at a 2θ scanning range of 20°–60°, with a step size 
of 0.05°. The average crystalline sizes were estimated using 
the Scherrer equation – Equation 2, where D is the mean size of 
the crystalline domains and β is the full width at half maximum 
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X-ray photoelectron spectroscopy (XPS)
Chemical analysis of the mesoporous films before and after 
loading of the antibiotics and with and without the surface 
modification was performed by XPS. The equipment used 
was a Quantum 2000 scanning microscope (Physical Elec-
tronics, Inc., Chanhassen, MN, USA) with a 100 μm point 
diameter at a 5 nm analysis depth.
Contact angle
Static contact-angle measurements were performed on 
unmodified and DCDMS-treated mesoporous titania surfaces 
using Milli-Q water (ɣ=72.8 mN m-1, n=3). The instrument 
used was an Attension Theta optical tensiometer (KSV, 
Helsinki, Finland).
Atomic force microscopy (AFM)
Semi-contact or intermittent AFM mode was used to measure 
the surface topography of mesoporous films at two different 
scan sizes (1 and 0.5 μm). A conical tip with a length of 
200 nm and a radius of 5 nm attached to an NT-RTESPA 
cantilever was used to scan the samples. The AFM used was 
an NT-MDT model (Moscow, Russia).
Pore volume measurement





O exchange experiments using QCM-D (Q-sense E4, 
Biolin Scientific, Stockholm, Sweden). Mesoporous titania 
thin films were formed on Ti QCM-D sensors according to 
the procedure described earlier under “Preparation of mes-
oporous titania substrates”. A stable base-line was obtained 
by adding a flow of Milli-Q water onto the surfaces. Then the 
flow was exchanged to D
2
O to replace the H
2
O absorbed in 
the pores. The changes in the frequency (Δf ) were recorded, 





O. As a control, the experiments were 
also carried out on nonporous thin films. In the calculations, 





O was correlated by subtracting the mass 
increase obtained for the nonporous surface. The obtained Δf 
was used to calculate the mass change utilizing the Sauerbrey 
equation – Equation 3, where C is the mass sensitivity con-











Using these data together with film thickness obtained 
from SEM, the specific pore volume of the mesoporous titania 
thin films was calculated.
Drug uptake and release
The uptake and release of antibiotics from the mesopo-
rous titania surfaces were investigated in situ by QCM-D 
(Q-sense E4). Titanium QCM-D discs (QSX 310, Q-sense) 
were coated with mesoporous and nonporous titania. For the 
experiments performed with vancomycin and gentamicin, 
Milli-Q H
2
O was used as the solvent (1 wt% antibiotic) and 
the rinsing liquid. In the daptomycin experiments, DCDMS-
treated sensors were used and methanol was used as solvent 
(1 wt%) and rinsing liquid. All QCM-D experiments were 
performed under a constant flow of 50 mL min-1. The mass 
of the adsorbed drugs (ng cm-2) were calculated from the 




S. aureus (ATCC 25923 [American Type Culture Collection, 
Manassas, VA, USA]) and P. aeruginosa (ATCC 35984) 
were used to assess bacterial growth on the mesoporous 
titania with varied pore sizes both with and without incor-
porated antibiotics. One day before the experiments, a sterile 
10 μL loop was used to withdraw a single isolated colony 
from cultured agar plates of each bacterium to inoculate a 
centrifuge tube with 5 mL of tryptic soy broth. The inocu-
lated cells were cultured in a shaking incubator at 200 rpm 
for 18 hours at 37°C until they reached stationary phase for 
bacterial growth.
Bacterial growth
The optical density of the bacterial suspension was adjusted 
to 0.52 at 620 nm (estimated to give 109 colonies) using a 
plate reader (Spectramax M3 Multimode Microplate Reader; 
Molecular Devices LLC, Sunnyvale, CA, USA). Then, each 
bacterial solution was diluted at a ratio of 1:100 using simu-
lated body fluid (adapted from Oyane et al)41 supplemented 
with 1% fetal bovine serum (FBS), and 1 mL of the diluted 
solution was seeded onto each mesoporous titania sample. 
Bacteria were then cultured for 1 hour under standard 
culture conditions (5% CO
2
/95% air at 37°C) to promote the 
attachment of the bacteria onto the titania surfaces. After 1 
hour of culture, media containing the unattached planktonic 
bacteria was aspirated. The samples were rinsed once with 
PBS and fresh media (simulated body fluid +1% FBS) were 
placed onto each sample. Samples were cultured for another 
47 hours and at the end of this time period, they were rinsed 
three times with PBS. Each sample was placed inside a sterile 





































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1




Antimicrobial performance of mesoporous titania thin films
were vortexed at 3,000 rpm for 2 minutes to release adher-
ent bacteria into the PBS solution. Afterward, each bacterial 
solution was diluted twice, 1:10, and then each dilution was 
plated as five 10 μL spots onto sterile tryptic soy broth agar 
plates. Agar plates were allowed to dry and were then placed 
inside an incubator at 37°C and 5% CO
2
 to allow colonies 
to grow. Once the colonies grew to a point permissive to 
visual counting (~18 hours), agar plates were taken out of 
the incubator and individual colonies were counted. From 
this number, the total number of colonies per milliliter of 
vortexed solution was calculated and converted to colony- 
forming units per milliliter.
Statistical analysis
The numerical data from counting the colony-forming units 
were presented by the mean value with the standard deviation. 
All the experiments were conducted three times with three 
replicates used for each experiment. Statistical significance 
was considered at P0.05.
Results
Material characterization
SEM micrographs of the coated titanium surfaces showed 
that the mesoporous titania films were evenly distributed and 
fully covered the substrate, Figures 2 and S1. A well-defined 
porous structure was revealed, which had accessible pores 
facing out from the surfaces. Cross-sections of the coatings 
were also visualized by SEM (Figure 3), which provided 
film-thickness estimations. The film thickness was ~200 nm 
for the films synthesized with the template P123 and CTAB, 
while a thicker coating of ~700 nm was obtained for the films 
when the swelling agent PPG was added. The mesoporous 
titania was also investigated using TEM, Figure 4. The aver-
age pore diameter and the pore density per surface area were 
calculated directly from the SEM and TEM micrographs and 
are presented in Figure 5 and Table 1. From the measured 
pore sizes, it is clear that the pore diameters correlated well 
with the size of the template, that is, larger templates resulted 
in larger pores.
Results from the SAXS measurements are presented in 
Figure 6. Visible Bragg peaks emerged at different positions, 
with various intensities demonstrating long-range periodicity 
in the porous structures. Nonporous samples did not show 
any peaks in the SAXS results, as expected.
XRD results showed the formation of crystalline anatase 
TiO
2
 with no significant difference among the different 
samples, including the nonporous titania. In Figure 7, a rep-
resentative diffractogram for the titania films is shown. The 
peak positions for anatase (mincryst#191) are also included in 
the figure. The crystal size was calculated to be ~6 nm using 
the Scherrer equation (Equation 2). The pore volume of the 





O exchange experiments using the mass differ-
ence between water and heavy water, Table 2.
Results from XPS are shown in Table 3 as the sur-
face chemical composition given in atomic percentage. 
Figure 2 SEM micrographs of mesoporous titania synthesized with different templates presented at two different magnifications.
Notes: (A) CTAB, (B) P123, and (C) P123 + PPg (1:1).
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No significant differences could be observed between the 
different surfaces.
In Table 4, the obtained average surface roughness values 
of the films for two different scan sizes are shown. From the 
results, only small variations in surface roughness values 
(Ra) could be observed for the different mesoporous films. 
The nonporous films were shown to have a smoother surface 
compared to the porous surfaces. The surface with a 6 nm 
pore size was shown to have a slightly rougher surface than 
the other two pore sizes.
The measured static contact angles were less than 5° 
for all unmodified mesoporous titania films. After surface 
modification with DCDMS, significantly higher contact 
angles were obtained (Table 5).
Drug uptake and delivery from 
mesoporous titania surfaces
The drug uptake and delivery from the mesoporous thin 
films were monitored using QCM-D. The results clearly 
demonstrated the loading capacity as well as the release 
profile for the three antibiotics from the investigated films. 
In Figure 8, the amount of drug (ng/cm2) as a function 
of time is presented. The experimental procedure was as 
follows: first the drug solution was injected and the drug 
loading could be determined; second, the surfaces were 
rinsed with pure solvent and the release was monitored. 
As can be seen in the figure, the drug-loading capacity 
increased with increasing pore size. Relatively fast release 
of the drugs was observed, especially for daptomycin. 
For gentamicin, no observable difference could be seen 
between the mesoporous surface having a pore size of 
4 nm and the nonporous, indicating that 4 nm is too small 
for gentamicin to penetrate into the porous network. No 
considerable changes were observed in the dissipation 
(ΔD) during the loading and releasing of all drugs dur-
ing the QCM-D measurements. XPS measurements were 
performed on the drug-loaded surfaces to confirm the 
presence of drugs. In Table 6, the identified elements are 
presented as atomic %. The presence of nitrogen indicates 
the occurrence of drugs.
Figure 3 SEM micrographs of the mesoporous titania coating cross-sections on 
glass slides.
Notes: (A) CTAB, (B) P123, and (C) P123 + PPg (1:1).
Abbreviations: SEM, scanning electron microscopy; CTAB, cetyltrimethylam-
monium bromide; P123, Pluronic® P123; PPG, polypropylene glycol.
Figure 4 TEM images of mesoporous titania synthesized with the different templates.
Notes: (A) CTAB, (B) P123, and (C) P123 + PPg (1:1).
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Antimicrobial performance of mesoporous titania thin films
Bacterial adhesion
The results from bacterial adhesion of S. aureus and 
P. aeruginosa are shown in Figure 9. There was a significant 
decrease in the attachment of colonies for both types of bacte-
ria on the antibacterial loaded surfaces for all antibiotics used. 
Surfaces with larger pore sizes and loaded with antibiotics 
gave rise to less colony forming units on the surfaces. Less 
bacterial attachment was observed on the hydrophobic sur-
faces and the lowest bacterial adhesion was on hydrophobic 
substrates loaded with daptomycin (Figure 9).
Furthermore, the presence of the pores alone had a desir-




Mesoporous titania thin films with pore diameters of 4, 6, 
and 7 nm were successfully formed as shown by TEM and 
SEM analysis. According to SEM, uniform films with pores 
accessible from the surface, which according to SAXS had 
a long-range order, were formed. Relatively broad peaks 
appeared in the SAXS data, indicating that the degree of order 
was relatively low, which is probably a result of the spin-
coating technique used. When dip coating was used instead of 
spin coating, a higher degree of ordering was often observed; 
however, less homogeneous films were then formed.42,43 
The ordering of the material was not considered to be of high 
significance in this particular application; however, the fact 
that the pores are present on the outer surface is a prerequisite 
for these coatings to function as drug-delivery matrices. When 
PPG was used as a swelling agent, thicker coatings (700 nm 
instead of 200 nm) were obtained, which is probably due to 
the viscosity increase for the PPG-containing solution used 
in the spin-coating process. The crystalline structure of all the 
formed films (according to XRD) was anatase TiO
2
. However, 
a large degree of amorphous titania is also to be expected. The 
Bragg peaks were broad, indicating that the crystal size was 
small (6 nm), which correlates well with previous studies.43 
XPS showed that the surface chemistry was similar on all the 
formed films, including the nonporous films, and consisted of 
carbon, oxygen, and titanium. The surface roughness values, 
as obtained from AFM, showed that the films were smooth, 
Figure 5 Data from average pore size calculations of mesoporous titania thin films 
using ten representative SEM and TEM micrographs with the same magnification.
Note: Values are mean ± standard error of the mean.
Abbreviations: SEM, scanning electron microscopy; TEM, transmission electron 
microscopy; CTAB, cetyltrimethylammonium bromide; P123, Pluronic® P123; PPG, 
polypropylene glycol.
Table 1 Estimated average pore sizes measured from SEM and 
TEM images
Template Average pore  
diameter




P123 + PPg (1:1) 7 42
Abbreviations: SEM, scanning electron microscopy; TEM, transmission electron 
microscopy; CTAB, cetyltrimethylammonium bromide; P123, Pluronic® P123; PPG, 
polypropylene glycol.
θ °
Figure 6 Synchroton small angle X-ray scattering diffractograms of mesoporous titania.
θ °
Figure 7 A representative X-ray diffractogram obtained from mesoporous titania 
powders.
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All the different material characterizations performed 
here clearly demonstrated that the chemistry and physical 
properties of the different porous materials were similar or 
in some cases even identical, which provides a possibility 
to explore the effect of the pore size alone on drug loading 
and release as well as antibacterial properties.
Antibiotic loading and delivery from 
mesoporous titania thin films
A key parameter in creating a suitable drug delivery coating 
is the loading capacity. According to the obtained results, 
the loading behavior of each drug corresponded well with 
the volume of the pores as measured by H
2
O adsorption. The 
larger pore sizes had the ability to host larger amounts of 
drugs per surface area of the coating, which was demonstrated 
by the QCM-D results when the mesoporous thin films were 
loaded with, for example, vancomycin (Figure 8). The size of 
vancomycin is ~3 nm, allowing it to be successfully loaded 
into all the explored pore-sizes.44 For gentamicin, a successful 
loading was observed for the mesoporous titania with pore 
sizes of 6 and 7 nm followed by a sustained-release pattern, 
Figure 8. For the 4 nm pore size, however, no difference 
compared with the nonporous surfaces could be observed, 
indicating that gentamicin could not access the 4 nm pores. 
This is explained by the fact that gentamicin is believed to 
have an affinity to titania that may create blockage of the 
pore walls upon adsorption. When comparing the release 
data of vancomycin and gentamicin, a difference in the 
release kinetics could be observed. Vancomycin had a faster 
release, indicating that the drug had only a low adherence to 
Table 2 The water-accessible pore volume of the mesoporous 
titania thin films obtained from QCM-D measurements
Template Pore volume percentage (%)
Pure titania films DCDMS treated films
P123 + PPg (1:1) 75 71
P123 57 55
cTaB 55 49
Note: Results for non-treated and DCDMS treated mesoporous titania thin films 
are shown.
Abbreviations: QCM-D, quartz crystal microbalance with dissipation monitoring; 
DCDMS, dichlorodimethylsilane; CTAB, cetyltrimethylammonium bromide; P123, 
Pluronic® P123; PPG, polypropylene glycol.
Table 3 The atomic percentage of the chemical composition on 
the mesoporous titania thin films
Template C1s O1s Ti2p
P123 + PPg 26.85 53.88 19.03
cTaB 24.79 55.32 19.16
P123 20.7 57.43 21.88
Abbreviations: CTAB, cetyltrimethylammonium bromide; P123, Pluronic® P123; 
PPG, poly propylene glycol.
Table 4 Average roughness (Ra) obtained by atomic force 
microscopy (AFM) from mesoporous titania surfaces in two 
different scan sizes
Average roughness (Ra) by AFM (nm)





Table 5 Contact-angle results before and after DCDMS modification
Surface Contact angle (°)  
on pure titania
Contact angle (°) after 
DCDMS treated
4 nm 5 85
6 nm 5 80
7 nm 5 110
Nonporous 7 100
Abbreviation: DCDMS, dichlorodimethylsilane.
with no major changes in the roughness for the different 
pore sizes. This shows that the cantilever tip was too broad 
to reach inside the pores and hence scanned above the porous 
structure. The use of narrower cantilevers, less than 5 nm 
in width, was tested; however, these also failed to provide 
measurements of the actual pores. The only considerable 
difference in surface roughness could be observed between 
the porous and nonporous surfaces; however, all were still 
considered to be smooth on a micrometer length scale. 
The surface energy of the films was examined using static 
contact-angle measurements, which showed that all surfaces 
were hydrophilic or even super hydrophilic. After surface 
modification with DCDMS, the surface energy drastically 
decreased, forming hydrophobic (contact angles above 90°) 
or close to hydrophobic surfaces. This provides clear evidence 
that the polar hydroxyl groups had been substituted with the 
non-polar methylene groups of the DCDMS.
The water-accessible pore volume was examined using 
QCM-D. As expected, the volume increased with increasing 
pore size and increased film thickness. The fact that the vol-
ume increased with film thickness, is a strong indication that 
the pores are accessible throughout the whole film, and thus 
makes it possible to tune the available drug-loading capac-
ity by altering films thickness, which is achievable through 
changes in the spin-coating speed as well as other parameters. 
The DCDMS modified films showed a small decrease in pore 
volume compared to their non-treated counterparts. This 
shows that, although the surfaces were hydrophobic, water 
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Antimicrobial performance of mesoporous titania thin films
the pore walls and, instead, was highly dissolved in the water 
within the pores; hence the measured frequency difference 
between water and the vancomycin solution was due to the 
difference in density between the two. The third antibiotic 
used was daptomycin, which is a larger molecule compared 
to the other two antibiotics. It also has a low water solubility; 
thus, DCDMS-modified surfaces were used for this drug. 
According to Figure 8, a trend in the loading was observed, 
which followed the expected tendency with increasing drug 
amount as the pore size increased. Upon rinsing with metha-
nol, a relatively fast release was observed. Apart from key 
parameters, including pore size and the available surface area, 
Figure 8 QCM-D results obtained from loading and release of the three different antibiotics.
Notes: (A) Gentamicin, (B) vancomycin, and (C) daptomycin on mesoporous titania with variable pore sizes (for daptomycin DCDMS-modified surfaces were used). 
*Indicates start of rinsing with solvent following the release.
Abbreviations: QCM-D, quartz crystal microbalance with dissipation monitoring; DCDMS,  dichlorodimethylsilane; min, minutes.
Table 6 XPS data showing the chemical composition (atomic %) of mesoporous titania with a pore size of 6 nm and nonporous titania 
thin films after loading with vancomycin, daptomycin, and gentamicin antibiotics
Samples Antibiotic C1s N1s O1s Ti2p Si2p
Mesoporous titania Vancomycin 20.55 5.87 55.03 18.55
Nonporous titania 16.03 0.30 59.82 23.85
Mesoporous titania Daptomycin 20.89 5.30 55.54 16.78 1.50
Nonporous titania 15.89 0.29 59.22 24.60
Mesoporous titania gentamicin 26.94 6.29 48.89 17.89
Nonporous titania 15.03 0.33 59.66 24.99
Note: The data are presented as atomic %.
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Figure 9 Data from counting the colony-forming units (CFU) grown on mesoporous titania with and without antibiotics.
Notes: (A) Gentamicin, (B) vancomycin, and (C) daptomycin. Values are mean ± standard error of the mean, N=3, *P0.05 compared to all mesoporous titania surfaces 
of the same pore size.
Abbreviation: DCDMS, dichlorodimethylsilane.
Figure 10 Data from counting the colony-forming units (CFU) grown on modified 
and unmodified mesoporous titania without the presence of antibiotics.
Notes: Values are mean ± standard error of the mean, N=3, *P0.05 compared to 
mesoporous titania surfaces for each bacterial strain.
Abbreviations: DCDMS, dichlorodimethylsilane; MPT, mesoporous titania.
the characteristics of the drugs (such as size and polarity) 
clearly played an important role. The dissipation (ΔD) did 
not change noticeably during the loading and releasing of 
drugs as a function of time. This observation indicates that 
there were no viscoelastic films formed due to adsorption of 
drugs onto the mesoporous thin films.
It should be noted that all drug-release studies were 
monitored upon constant rinsing with the solvent, water or 
methanol, at a rate of 50 mL min-1. Compared to an in vivo 
situation, for example in bone tissue, this is a much faster 
exchange of surrounding media resulting in a much faster 
release and, consequently, the present release profiles cannot 
be directly transferred to the clinical situation and should be 
considered highly accelerated.
Bacterial cell culture
Early clinical failure of implants often arises from improper 
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of a bacterial biofilm and chronic infection at the site of sur-
gery. Previous studies have emphasized the possible fabrica-
tion of antimicrobial surfaces using nanotechnology; although 
applying nanotechnology to create roughness values in the 
nanometer regime on the implant surfaces needs to be further 
addressed.45–47 Results from this present study showed that 
applying a mesoporous thin coating on surfaces, apart from 
their function as an antibiotic-delivery system, can reduce 
the adhesion of bacteria only by the presence of nano-sized 
pores. S. aureus showed a reduced bacterial attachment on 
surfaces with smaller pore sizes, 4 and 6 nm, and a trend in 
the reduction of P. aeruginosa was observed with reducing 
pore size. Looking at the measured material characteristics 
(including surface energy, surface roughness, and surface 
chemistry), in an effort to find a reasonable explanation for 
the observed bacterial behavior, no obvious connections 
could be found. For both bacteria, the smallest pore size had 
the lowest bacterial adhesion; however, this material did not 
exhibit any unique material characteristics, except for the 
change in pore size. A possible explanation for the observed 
trend is that protein adsorption and bioactivity are affected 
by the changes in the nanotopography caused by changing 
the pore width. Moreover, the distribution of the pores (pore 
surface coverage shown in Table 1) and consequently the 
pore wall thickness differs due to the changes in pore width. 
It is known that the 3D conformation of proteins, which is 
present in the bacterial growth media, can be altered by 
changes in the nanotopography, which can potentially have 
an effect on bacterial adhesion.48 Similar behavior of bacte-
rial attachment responses by changing the nanotopography 
have previously been observed regarding the use of carbon 
nanotubes and nanostructured gold surfaces.23,49 Moreover, 
the formed mesoporous materials have a long-range order, 
something that has been previously shown to affect cell 
responses.50 This implies that apart from the traditional means 
of characterizing biomaterials, both when it comes to tissue 
integration properties as well as antimicrobial behaviors, 
studies should be performed with respect to ordering and 
size of nanostructured domains.
According to the results obtained from counting colony 
forming units, the best surfaces to reduce bacterial attach-
ments without the presence of antibiotics was the hydropho-
bic mesoporous titania with 4 nm pore sizes showing that 
the bacterial attachment was lower when the surface energy 
of the substrate decreased. It is not clear whether it is the 
surface free energy of the substrates that directly controls 
the bacterial adhesion or the fact that adsorption of the FBS, 
present in the culture medium, is affected, thus reducing 
bacterial adhesion. Similar behavior has been observed with 
BSA, which decreases bacterial attachment on hydrophobic 
polystyrene substrates.51 Moreover, it has previously been 
shown that the presence of FBS in the culture medium has 
a negative effect on the adhesion of cells on hydrophobic 
surfaces.52
When the mesoporous titania was loaded with antibiotics, 
a predictable pattern was observed. According to Table 2, 
the pore volume increased with increasing pore size and the 
results from QCM-D measurements clearly showed that the 
amount of antibiotics followed the same trend. These observa-
tions correlated well with the bacterial adhesion results, which 
showed clear differences in the adhesion of bacteria when 
different antibiotic loadings were used. Regardless of the type 
of antibiotic and the bacteria, an expected decreased attach-
ment was observed with increased amounts of antibiotics. 
These observations confirm that the mesoporous titania sub-
strates can act as an efficient drug release coating on implants 
to fight bacterial adhesion and potential infection caused by 
the formation of biofilms. The amount of antibiotic loaded 
in the coating can be regulated by varying the pore size and 
the thickness of the mesoporous titania film.
As mentioned earlier, the use of mesoporous titania 
thin films as implant coatings has previously been shown 
to have promising effects on the osseointegration of tita-
nium implants.53 The integration of such implants was 
further improved using osteoporosis drugs, alendronate 
and raloxifene, which were administrated locally from the 
mesoporous film.23 Both the mechanical stability and the 
amount of formed bone were shown to increase. The results 
from this present study also showed an additional favorable 
property of the mesoporous films, that is, that they also 
decreased bacterial adhesion, both with and without the use of 
antibiotics. This is a highly desirable property, which clearly 
demonstrates that the use of nanostructural surface design is 
important when the “race for the surface” is of the essence; 
here providing a means for tissue growth and a reduced risk 
for BAIs. The use of drugs in implantology, especially when 
the implant functions as a drug-delivery device, is still in its 
infancy, something highly driven by the regulatory legisla-
tion; however, as demonstrated by us and others, could be 
highly beneficial. The use of local drug administration is 
a way to decrease the amount of drugs used and to obtain 
site-specific efficient treatment. The occurrence of a possible 
negative side effect might also be hindered, although this 
needs to be further investigated.
Conclusion
Mesoporous titania thin films with well-defined pore sizes 
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with and without antimicrobial agents, including gentamicin, 
vancomycin, and daptomycin were evaluated with respect 
to bacterial attachment. The mesoporous titania films were 
shown to have a desired property in reducing bacterial 
attachment and a declining trend was observed as a function 
of pore size. The antibiotic loading was shown to improve 
antimicrobial behavior for all surfaces and the effect corre-
lated well with the amount of the released drug. Moreover, 
the present hydrophobic modification of the mesoporous 
titania films decreased the adhesion of bacteria.
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Figure S1 SEM micrographs of mesoporous titania coated onto glass substrates synthesized by different templates.
Notes: (A) CTAB, (B) P123, and (C) P123 + PPg (1:1). 
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